AUTHOR=Yang Yu-shan , Pei Ying-hao , Gu Yuan-yuan , Zhu Jun-feng , Yu Peng , Chen Xiao-hu TITLE=Association between short-term exposure to ambient air pollution and heart failure: An updated systematic review and meta-analysis of more than 7 million participants JOURNAL=Frontiers in Public Health VOLUME=10 YEAR=2023 URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.948765 DOI=10.3389/fpubh.2022.948765 ISSN=2296-2565 ABSTRACT=Introduction

Exposure to air pollution has been linked to the mortality of heart failure. In this study, we sought to update the existing systematic review and meta-analysis, published in 2013, to further assess the association between air pollution and acute decompensated heart failure, including hospitalization and heart failure mortality.

Methods

PubMed, Web of Science, EMBASE, and OVID databases were systematically searched till April 2022. We enrolled the studies regarding air pollution exposure and heart failure and extracted the original data to combine and obtain an overall risk estimate for each pollutant.

Results

We analyzed 51 studies and 7,555,442 patients. Our results indicated that heart failure hospitalization or death was associated with increases in carbon monoxide (3.46% per 1 part per million; 95% CI 1.0233–1.046, P < 0.001), sulfur dioxide (2.20% per 10 parts per billion; 95% CI 1.0106–1.0335, P < 0.001), nitrogen dioxide (2.07% per 10 parts per billion; 95% CI 1.0106–1.0335, P < 0.001), and ozone (0.95% per 10 parts per billion; 95% CI 1.0024–1.0166, P < 0.001) concentrations. Increases in particulate matter concentration were related to heart failure hospitalization or death (PM2.5 1.29% per 10 μg/m3, 95% CI 1.0093–1.0165, P < 0.001; PM10 1.30% per 10 μg/m3, 95% CI 1.0102–1.0157, P < 0.001).

Conclusion

The increase in the concentration of all pollutants, including gases (carbon monoxide, sulfur dioxide, nitrogen dioxide, ozone) and particulate matter [(PM2.5), (PM10)], is positively correlated with hospitalization rates and mortality of heart failure.

Systematic review registration

https://www.crd.york.ac.uk/PROSPERO/, identifier: CRD42021256241.